// App-Quantinova.ai

512 : Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19

Researchers

Presenter

  • Hanny Al-Samkari

Principal Investigators

  • Fei Song

  • Elizabeth M. Van Cott

  • David J. Kuter

  • Rachel P. Rosovsky

Medical Centers

  • Harvard Medical School, Boston, MA

  • Division of Rheumatology, Massachusetts General Hopsital, Boston, MA,

  • Massachusetts General Hospital, Boston, MA

  • Department of Pathology, Massachusetts General Hospital, Boston, MA

  • Nephrology Division, Massachusetts General Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • Prothrombin

  • D-dimer

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved